TREACY WILLIAMS: Open Payments
NPI 1477184299 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 45 payments from 16 companies in 2025. Trend: 2023 $697 · 2024 $745 · 2025 $1,083
Food & beverage: $978Education: $104
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 9 | $158 |
| Teva Pharmaceuticals USA, Inc. | 4 | $148 |
| ABBVIE INC. | 4 | $122 |
| Axsome Therapeutics, Inc. | 5 | $95 |
| Alkermes, Inc. | 4 | $94 |
| Supernus Pharmaceuticals, Inc. | 4 | $93 |
| Janssen Pharmaceuticals, Inc | 2 | $77 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $49 |
| Collegium Pharmaceutical, Inc. | 2 | $43 |
Products named: INGREZZA, VRAYLAR, Auvelity, ARISTADA, Qelbree, REXULTI, CAPLYTA, INVEGA SUSTENNA.
Industry payments across MO — which companies pay providers there.
